Ryogo Umetsu
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacology top 10%
- Drug-Induced Adverse Reactions
- Pharmacy and Medical Practices
Papers in
- Toxicology 12
- Pharmacovigilance and Adverse Drug Reactions 12
-
- Pharmacy and Medical Practices 4
- Drug-Induced Adverse Reactions 3
- Co-authors
- Mitsuhiro Nakamura (21 shared papers)Junko Abe (16 shared papers)Yasutomi Kinosada (15 shared papers)Yamato Kato (15 shared papers)Natsumi Ueda (15 shared papers)Yôko Nakayama (10 shared papers)Toshinobu Matsui (9 shared papers)Sayaka Sasaoka (8 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (3 papers)International Journal of Medical Sciences (2 papers)Frontiers in Pharmacology (1 paper)PLoS ONE (1 paper)BMC Pharmacology and Toxicology (1 paper)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Ryogo Umetsu
21 papers receiving 462 citations
Peers
Comparison fields: 5 of 82
- Toxicology 168
- Pharmacology 77
- Geriatrics and Gerontology 27
- Pharmacology 110
- Biological Psychiatry 12
Countries citing papers authored by Ryogo Umetsu
This map shows the geographic impact of Ryogo Umetsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryogo Umetsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryogo Umetsu more than expected).
Fields of papers citing papers by Ryogo Umetsu
This network shows the impact of papers produced by Ryogo Umetsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryogo Umetsu. The network helps show where Ryogo Umetsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryogo Umetsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 71 | |
| 2 | 2015 | 58 | |
| 3 | 2015 | 54 | |
| 4 | 2015 | 36 | |
| 5 | 2017 | 29 | |
| 6 | 2015 | 26 | |
| 7 | 2017 | 24 | |
| 8 | 2015 | 23 | |
| 9 | 2015 | 22 | |
| 10 | 2018 | 20 | |
| 11 | 2016 | 18 | |
| 12 | 2014 | 18 | |
| 13 | 2021 | 15 | |
| 14 | 2015 | 12 | |
| 15 | 2015 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2018 | 8 | |
| 18 | 2017 | 7 | |
| 19 | 2015 | 4 | |
| 20 | 2015 | 3 |
About Ryogo Umetsu
Ryogo Umetsu is a scholar working on Toxicology, Pharmacology, Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health, having authored 21 papers that have together received 467 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (12 papers), Pharmacy and Medical Practices (4 papers), Pharmaceutical studies and practices (3 papers), Drug-Induced Adverse Reactions (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Diabetes Management and Research (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Toxicology (168 citations), Pharmacology (77 citations), Geriatrics and Gerontology (27 citations), Pharmacology (110 citations) and Biological Psychiatry (12 citations). Ryogo Umetsu has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Mitsuhiro Nakamura, Junko Abe, Yasutomi Kinosada, Yamato Kato, Natsumi Ueda, Yôko Nakayama, Toshinobu Matsui, Sayaka Sasaoka, Yumi Motooka and Haruna Hatahira. Their work appears in journals such as Biological and Pharmaceutical Bulletin, International Journal of Medical Sciences, Frontiers in Pharmacology, PLoS ONE and BMC Pharmacology and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.